Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cat Triple Inactivated Vaccine (Tangshan Yian Biological Engineering)
- Development stage
- Unknown
- Lead developer
- Tangshan Yian Biological Engineering
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
The Cat Triple Inactivated Vaccine, developed by Tangshan Yian Biological Engineering, is a veterinary vaccine designed to protect cats against three major viral diseases: feline panleukopenia (caused by feline parvovirus), feline viral rhinotracheitis (caused by feline herpesvirus type 1), and feline calicivirus infection. As an inactivated (killed) vaccine, it contains viral particles that have been treated to lose their disease-causing capability while remaining able to stimulate the feline immune system. Upon administration, the vaccine elicits both protective antibody and cellular immune responses, providing immunity against these common and potentially severe feline pathogens. It is currently approved for use in the veterinary market.
- Other names
- 猫三联灭活疫苗Feline Triple Inactivated Vaccine
02
Targets
FPV (Feline panleukopenia virus)
Beyond the preview
Go deeper on Cat Triple Inactivated Vaccine (Tangshan Yian Biological Engineering).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cat Triple Inactivated Vaccine (Tangshan Yian Biological Engineering).